Fundamental Analysis
31 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +13.7% | -67.8% | 1 / 3 | +9.0% | +3.44 pp | +0.07 pp | +2.2% | 1.12 | 30.20 | 4.150 | +9,0% | 103 | +12,1% | 30.20 | 10.60 | +184,9% |
| Pts | 0 | 0 | 4 | 0 | 12 | 8 | 0 | 6 | 4 | |||||||
Valuation annotation:Price: 10.600 (close price on 2026-10-19)EPS (TTM): 351,0
Financial charts
1.Revenue & growth
VND bn4.150Q2/26
1.Revenue & growth
VND bn4.150Q2/26
2.Profit & growth
VND bn104Q2/26
3.Profit mix (Penman)
VND bn236Q2/26
4.Margins & cost structure
%5.4%Q2/26
5.Returns & cash cycle
% · days1.4%Q2/26
6.Earnings quality & cash
VND bn2.507Q2/26
7.Asset structure
VND bn18.454Q2/26
8.Funding & debt health
VND bn · times18.454Q2/26
9.Revenue backlog
VND bn205Q2/26
10.Valuation
times · %31,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %211Q2/26
Adjusted EPS growth, latest quarter
13.7%
Average adjusted EPS growth, 3 quarters
-62.7%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26